Richard T Kenney Sonnet Bio Therapeutics Holdings, Inc. (SONN) insider trading activity

Richard T Kenney is Chief Medical Officer of Sonnet BioTherapeutics Holdings, Inc.. Currently has a direct ownership of 9,374 shares of SONN, which is worth approximately $42,464. The most recent transaction as insider was on Jul 11, 2025, when has been sold 8,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.37K

582.24% 3M change

582.24% 12M change

Total Value Held $42,464

Richard T Kenney Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 11 2025	BUY Grant, award, or other acquisition	-	8,000 Added 46.05%	9,374 Common Stock
Dec 11 2023	BUY Grant, award, or other acquisition	-	1,271 Added 48.05%	1,374 Common Stock
Jan 07 2023	SELL Sale (or disposition) back to the issuer	-	14,627 Reduced 80.38%	3,571 Common Stock
Jan 07 2023	BUY Grant, award, or other acquisition	-	14,627 Added 44.56%	18,198 Common Stock
Dec 14 2022	BUY Grant, award, or other acquisition	-	14,627 Added 18.46%	64,627 Common Stock
Jun 09 2021	BUY Open market or private purchase	$23,100 $1.54 p/Share	15,000 Added 23.08%	50,000 Common Stock
May 19 2021	BUY Open market or private purchase	$15,500 $1.55 p/Share	10,000 Added 22.22%	35,000 Common Stock
Mar 25 2021	BUY Grant, award, or other acquisition	-	25,000 Added 50.0%	25,000 Common Stock

RTK

Richard T Kenney

Chief Medical Officer

Princeton, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SONN shares.

Notify only if

Value

Insider Trading

Get notified when an Sonnet Bio Therapeutics Holdings, Inc. insider buys or sells SONN shares.

Notify only if

Operation

Value

Type

News

Receive news related to Sonnet BioTherapeutics Holdings, Inc.

Track Activities on SONN

Account